Skip to main content
SpringerLink
Log in

Aortic and Pulmonic Valvular Heart Disease

  • Chapter
  • First Online:
MGH Cardiology Board Review

  • 1331 Accesses

Abstract

Valvular heart disease is a growing public health concern. Over the past century, there has been a shift in the primary etiology of valvular heart disease in industrialized nations. Rheumatic heart disease, which remains the most common etiology of heart valve disease globally, has become rare in western countries while degenerative valvular disease has become more common. The prevalence of degenerative heart valve disease increases with age and, consequently, the prevalence of heart valve disease is increasing with the aging population in western countries.

Valvular heart disease is an expansive topic encompassing numerous disease entities, complex hemodynamics, invasive and noninvasive testing, and involved management decisions. In addition, perhaps more so than any other topic in cardiology, the diagnosis and management of valvular heart disease is dependent on the history and physical examination. Such complexity makes valvular heart disease a prime topic for cardiology board examinations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002–12.

    Article  PubMed  Google Scholar 

  2. Selzer A. Changing aspects of the natural history of valvular aortic stenosis. N Engl J Med. 1987;317(2):91–8.

    Article  CAS  PubMed  Google Scholar 

  3. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001;103(11):1522–8.

    Article  PubMed  Google Scholar 

  4. O'Brien KD, Shavelle DM, Caulfield MT, McDonald TO, Olin-Lewis K, Otto CM, et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation. 2002;106(17):2224–2230.

    Google Scholar 

  5. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90(2):844–53.

    Article  CAS  PubMed  Google Scholar 

  6. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation. 2003;107(17):2181–4.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Goldbarg SH, Elmariah S, Miller MA, Fuster V. Insights into degenerative aortic valve disease. J Am Coll Cardiol. 2007;50(13):1205–13.

    Article  PubMed  Google Scholar 

  8. Michelena HI, Desjardins VA, Avierinos JF, Russo A, Nkomo VT, Sundt TM, et al. Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation. 2008;117(21):2776–84.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Roberts WC, Janning KG, Ko JM, Filardo G, Matter GJ. Frequency of congenitally bicuspid aortic valves in patients >/=80 years of age undergoing aortic valve replacement for aortic stenosis (with or without aortic regurgitation) and implications for transcatheter aortic valve implantation. Am J Cardiol. 2012;109(11):1632–6.

    Article  PubMed  Google Scholar 

  10. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57–185.

    Article  PubMed  Google Scholar 

  11. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159–95.

    Article  PubMed  Google Scholar 

  12. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22(19130998):1–23.

    PubMed  Google Scholar 

  13. Genereux P, Stone GW, O'Gara PT, Marquis-Gravel G, Redfors B, Giustino G, et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2016;67(19):2263–88.

    Article  PubMed  Google Scholar 

  14. Redfors B, Pibarot P, Gillam LD, Burkhoff D, Bax JJ, Lindman BR, et al. Stress testing in asymptomatic aortic stenosis. Circulation. 2017;135(20):1956–76.

    Article  PubMed  Google Scholar 

  15. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118(15):e523–661.

    PubMed  Google Scholar 

  16. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I. Am Heart J. 1951;41(1):1–29.

    Article  CAS  PubMed  Google Scholar 

  17. Hakki AH, Iskandrian AS, Bemis CE, Kimbiris D, Mintz GS, Segal BL, et al. A simplified valve formula for the calculation of stenotic cardiac valve areas. Circulation. 1981;63(5):1050–5.

    Article  CAS  PubMed  Google Scholar 

  18. Pibarot P, Dumesnil JG. Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction. J Am Coll Cardiol. 2012;60(19):1845–53.

    Article  PubMed  Google Scholar 

  19. Clavel MA, Messika-Zeitoun D, Pibarot P, Aggarwal SR, Malouf J, Araoz PA, et al. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. J Am Coll Cardiol. 2013;62(24):2329–38.

    Article  CAS  PubMed  Google Scholar 

  20. Clavel MA, Pibarot P, Messika-Zeitoun D, Capoulade R, Malouf J, Aggarval S, et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol. 2014;64(12):1202–13.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Lloyd JW, Nishimura RA, Borlaug BA, Eleid MF. Hemodynamic response to nitroprusside in patients with low-gradient severe aortic stenosis and preserved ejection fraction. J Am Coll Cardiol. 2017;70(11):1339–48.

    Article  CAS  PubMed  Google Scholar 

  22. Otto CM, Pearlman AS, Gardner CL. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. J Am Coll Cardiol. 1989;13(3):545–50.

    Article  CAS  PubMed  Google Scholar 

  23. Cheitlin MD, Gertz EW, Brundage BH, Carlson CJ, Quash JA, Bode RS Jr. Rate of progression of severity of valvular aortic stenosis in the adult. Am Heart J. 1979;98(6):689–700.

    Article  CAS  PubMed  Google Scholar 

  24. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000;343(9):611–7.

    Article  CAS  PubMed  Google Scholar 

  25. Novaro GM, Katz R, Aviles RJ, Gottdiener JS, Cushman M, Psaty BM, et al. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol. 2007;50(20):1992–8.

    Article  CAS  PubMed  Google Scholar 

  26. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.

    Article  CAS  PubMed  Google Scholar 

  27. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352(23):2389–97.

    Article  CAS  PubMed  Google Scholar 

  28. Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359(13):1343–56.

    Article  PubMed  Google Scholar 

  29. Chan KL, Teo K, Dumesnil JG, Ni A, Tam J. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010;121(2):306–14.

    Article  CAS  PubMed  Google Scholar 

  30. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–31.

    Article  PubMed  Google Scholar 

  31. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.

    Article  CAS  PubMed  Google Scholar 

  32. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790–8.

    Article  CAS  PubMed  Google Scholar 

  33. Eleid MF, Sorajja P, Michelena HI, Malouf JF, Scott CG, Pellikka PA. Flow-gradient patterns in severe aortic stenosis with preserved ejection fraction: clinical characteristics and predictors of survival. Circulation. 2013;128(16):1781–9.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet. 1986;1(8472):63–7.

    Article  CAS  PubMed  Google Scholar 

  35. Stout KK, Verrier ED. Acute valvular regurgitation. Circulation. 2009;119(25):3232–41.

    Article  PubMed  Google Scholar 

  36. Freeman RV, Otto CM. Aortic valve disease. In: Fuster V, Walsh R, Harrington R, editors. Hurst's the heart. 13th ed. New York, NY: McGraw-Hill; 2010.

    Google Scholar 

  37. Maroo A, Deedy M, Griffin BP. Aortic valve disease. In: Griffen BP, Topol EJ, editors. Manual of cardiovascular medicine. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.

    Google Scholar 

  38. Sellers RD, Levy MJ, Amplatz K, Lillehei CW. Left retrograde cardioangiography in acquired cardiac disease: technic, indications and interpretations in 700 cases. Am J Cardiol. 1964;14:437–47.

    Article  CAS  PubMed  Google Scholar 

  39. Bonow RO, Nikas D, Elefteriades JA. Valve replacement for regurgitant lesions of the aortic or mitral valve in advanced left ventricular dysfunction. Cardiol Clin. 1995;13(1):73–83.

    Article  CAS  PubMed  Google Scholar 

  40. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(23):e143–263.

    Article  PubMed  Google Scholar 

  41. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(23):e143–263.

    Article  PubMed  Google Scholar 

  42. Cheatham JP, Hellenbrand WE, Zahn EM, Jones TK, Berman DP, Vincent JA, et al. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial. Circulation. 2015;131(22):1960–70.

    Article  PubMed  Google Scholar 

  43. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Daniela R. Crousillat, Sheila Klassen, Sammy Elmariah, Jonathan J. Passeri & Igor F. Palacios

Authors
  1. Daniela R. Crousillat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sheila Klassen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sammy Elmariah
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jonathan J. Passeri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Igor F. Palacios
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Igor F. Palacios .

Editor information

Editors and Affiliations

  1. Cardiology Division, Massachusetts General Hospital, Boston, MA, USA

    Hanna K. Gaggin

  2. Cardiology Division, Massachusetts General Hospital, Boston, MA, USA

    James L. Januzzi Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Crousillat, D.R., Klassen, S., Elmariah, S., Passeri, J.J., Palacios, I.F. (2021). Aortic and Pulmonic Valvular Heart Disease. In: Gaggin, H.K., Januzzi Jr., J.L. (eds) MGH Cardiology Board Review. Springer, Cham. https://doi.org/10.1007/978-3-030-45792-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-45792-1_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-45791-4

  • Online ISBN: 978-3-030-45792-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation